PER 3.80% 7.6¢ percheron therapeutics limited

James Garner AKA JG, page-144

  1. 4,340 Posts.
    lightbulb Created with Sketch. 2023
    Dont forget DMD is a tiny subset of inflammation disease.
    The company has patent protection of the way ATL1102 works with cd49+. They have investigated the biomarkers.

    Dont under estimate the value of this platform drug.

    Think cortisone steroid replacement. But with better effectiveness and safety. Thats where this is being positioned.
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
7.6¢
Change
-0.003(3.80%)
Mkt cap ! $68.51M
Open High Low Value Volume
7.8¢ 7.8¢ 7.5¢ $47.57K 622.6K

Buyers (Bids)

No. Vol. Price($)
1 1598 7.6¢
 

Sellers (Offers)

Price($) Vol. No.
7.9¢ 140942 2
View Market Depth
Last trade - 16.10pm 08/08/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.